{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:35:08Z","timestamp":1791516908398,"version":"4.3.4"},"reference-count":50,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":4467,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Apolipoprotein CIII (apoCIII) is an independent risk factor for cardiovascular disease, but the molecular mechanisms involved are poorly understood. We investigated potential proatherogenic properties of apoCIII-containing LDL from hypertriglyceridemic patients with type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>LDL was isolated from control subjects, subjects with type 2 diabetes, and apoB transgenic mice. LDL-biglycan binding was analyzed with a solid-phase assay using immunoplates coated with biglycan. Lipid composition was analyzed with mass spectrometry. Hydrolysis of LDL by sphingomyelinase was analyzed after labeling plasma LDL with [3H]sphingomyelin. ApoCIII isoforms were quantified after isoelectric focusing. Human aortic endothelial cells were incubated with desialylated apoCIII or with LDL enriched with specific apoCIII isoforms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We showed that enriching LDL with apoCIII only induced a small increase in LDL-proteoglycan binding, and this effect was dependent on a functional site A in apoB100. Our findings indicated that intrinsic characteristics of the diabetic LDL other than apoCIII are responsible for further increased proteoglycan binding of diabetic LDL with high-endogenous apoCIII, and we showed alterations in the lipid composition of diabetic LDL with high apoCIII. We also demonstrated that high apoCIII increased susceptibility of LDL to hydrolysis and aggregation by sphingomyelinases. In addition, we demonstrated that sialylation of apoCIII increased with increasing apoCIII content and that sialylation of apoCIII was essential for its proinflammatory properties.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>We have demonstrated a number of features of apoCIII-containing LDL from hypertriglyceridemic patients with type 2 diabetes that could explain the proatherogenic role of apoCIII.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db09-0206","type":"journal-article","created":{"date-parts":[[2009,6,6]],"date-time":"2009-06-06T01:00:28Z","timestamp":1244250028000},"page":"2018-2026","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":129,"title":["ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan"],"prefix":"10.2337","volume":"58","author":[{"given":"Anne","family":"Hiukka","sequence":"first","affiliation":[{"name":"Department of Medicine, Helsinki University Central Hospital and Biomedicum, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"St\u00e5hlman","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Pettersson","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Levin","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Adiels","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Teneberg","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Cell Biology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva S.","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Helsinki University Central Hospital and Biomedicum, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillemor Mattsson","family":"Hult\u00e9n","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olov","family":"Wiklund","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Ore\u0161i\u010d","sequence":"additional","affiliation":[{"name":"Technical Research Centre of Finland VTT, Espoo, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Olof","family":"Olofsson","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Riitta","family":"Taskinen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Helsinki University Central Hospital and Biomedicum, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Ekroos","sequence":"additional","affiliation":[{"name":"Zora Biosciences, Espoo, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[{"name":"Sahlgrenska Center for Cardiovascular and Metabolic Research\/Wallenberg Laboratory and the Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2009,6,5]]},"reference":[{"key":"2022031215402714500_B1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.ATV.19.3.472","article-title":"Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3","volume":"19","author":"Jong","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031215402714500_B2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-2275(20)31574-1","article-title":"Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia","volume":"42","author":"Campos","year":"2001","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1194\/jlr.M500161-JLR200","article-title":"A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes","volume":"46","author":"Davidsson","year":"2005","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"2022031215402714500_B5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.ATV.0000066131.01313.EB","article-title":"LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients","volume":"23","author":"Lee","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031215402714500_B6","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"2022031215402714500_B7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI111711","article-title":"Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.","volume":"75","author":"Wang","year":"1985","journal-title":"J Clin Invest"},{"key":"2022031215402714500_B8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0014-5793(76)80145-7","article-title":"Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase","volume":"65","author":"Kinnunen","year":"1976","journal-title":"FEBS Lett"},{"key":"2022031215402714500_B9","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI119456","article-title":"Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.","volume":"99","author":"Ebara","year":"1997","journal-title":"J Clin Invest"},{"key":"2022031215402714500_B10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1194\/jlr.P600011-JLR200","article-title":"Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions","volume":"48","author":"Zheng","year":"2007","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B11","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1210\/jc.2003-032056","article-title":"Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity","volume":"89","author":"Cohn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031215402714500_B12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","article-title":"Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells","volume":"114","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"2022031215402714500_B13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.ATV.0000249620.68705.0d","article-title":"Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C \u03b1-mediated nuclear factor-\u03baB activation","volume":"27","author":"Kawakami","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031215402714500_B14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1194\/jlr.M200322-JLR200","article-title":"ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan","volume":"43","author":"Olin-Lewis","year":"2002","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1172\/JCI2265","article-title":"Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.","volume":"101","author":"Boren","year":"1998","journal-title":"J Clin Invest"},{"key":"2022031215402714500_B16","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1074\/jbc.273.5.2738","article-title":"Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.","volume":"273","author":"Schissel","year":"1998","journal-title":"J Biol Chem"},{"key":"2022031215402714500_B17","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1021\/bi00363a036","article-title":"Human lysosomal sphingomyelinase: substrate efficacy of apolipoprotein\/sphingomyelin complexes","volume":"25","author":"Ahmad","year":"1986","journal-title":"Biochemistry"},{"key":"2022031215402714500_B18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0022-2275(20)38224-9","article-title":"Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure","volume":"30","author":"Ito","year":"1989","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1373\/clinchem.2003.022541","article-title":"Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis","volume":"49","author":"Wopereis","year":"2003","journal-title":"Clin Chem"},{"key":"2022031215402714500_B20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1172\/JCI110532","article-title":"An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III","volume":"69","author":"Holdsworth","year":"1982","journal-title":"J Clin Invest"},{"key":"2022031215402714500_B21","doi-asserted-by":"crossref","first-page":"31348","DOI":"10.1074\/jbc.272.50.31348","article-title":"Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor","volume":"272","author":"Mann","year":"1997","journal-title":"J Biol Chem"},{"key":"2022031215402714500_B22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1194\/jlr.M500455-JLR200","article-title":"Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism","volume":"47","author":"Mauger","year":"2006","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B23","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00125-007-0751-8","article-title":"Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus","volume":"50","author":"Hiukka","year":"2007","journal-title":"Diabetologia"},{"key":"2022031215402714500_B24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.8.2.168","article-title":"Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes","volume":"8","author":"Taskinen","year":"1988","journal-title":"Arteriosclerosis"},{"key":"2022031215402714500_B25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9150(90)90131-2","article-title":"Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation","volume":"83","author":"Griffin","year":"1990","journal-title":"Atherosclerosis"},{"key":"2022031215402714500_B26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI1847","article-title":"Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100","volume":"101","author":"Boren","year":"1998","journal-title":"J Clin Invest"},{"key":"2022031215402714500_B27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.D700025-JLR200","article-title":"Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O\/sucrose or in KBr","volume":"49","author":"Stahlman","year":"2008","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Skalen","year":"2002","journal-title":"Nature"},{"key":"2022031215402714500_B29","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/ac015655c","article-title":"Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer","volume":"74","author":"Ekroos","year":"2002","journal-title":"Anal Chem"},{"key":"2022031215402714500_B30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-4347(97)00651-8","article-title":"Rapid separation and quantitation of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection","volume":"708","author":"Homan","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"2022031215402714500_B31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3891\/acta.chem.scand.49-0929","article-title":"Ganglioside extraction from erythrocytes: a comparison study","volume":"49","author":"Wang","year":"1995","journal-title":"Acta Chem Scand"},{"key":"2022031215402714500_B32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF00731304","article-title":"Comparison of the glycolipid-binding specificities of cholera toxin and porcine Escherichia coli heat-labile enterotoxin: identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine","volume":"11","author":"Teneberg","year":"1994","journal-title":"Glycoconj J"},{"key":"2022031215402714500_B33","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI118934","article-title":"Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.","volume":"98","author":"Schissel","year":"1996","journal-title":"J Clin Invest"},{"key":"2022031215402714500_B34","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1161\/01.ATV.0000168912.42941.60","article-title":"Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans","volume":"25","author":"Oorni","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031215402714500_B35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.ATV.0000117174.19078.85","article-title":"Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100","volume":"24","author":"Flood","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031215402714500_B36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-2275(20)33358-7","article-title":"Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content","volume":"40","author":"Khoo","year":"1999","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B37","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1016\/S0021-9258(18)37468-4","article-title":"The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells","volume":"263","author":"Aviram","year":"1988","journal-title":"J Biol Chem"},{"key":"2022031215402714500_B38","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0022-2275(20)41332-X","article-title":"Sphingomyelinase treatment of low density lipoprotein and cultured cells results in enhanced processing of LDL which can be modulated by sphingomyelin","volume":"33","author":"Gupta","year":"1992","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B39","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/bi00429a029","article-title":"Molecular packing of high-density and low-density lipoprotein surface lipids and apolipoprotein A-I binding","volume":"28","author":"Ibdah","year":"1989","journal-title":"Biochemistry"},{"key":"2022031215402714500_B40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0005-2760(90)90108-A","article-title":"Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids","volume":"1043","author":"Sola","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"2022031215402714500_B41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1388-1981(00)00123-2","article-title":"Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL","volume":"1488","author":"Hevonoja","year":"2000","journal-title":"Biochimica Biophysica Acta"},{"key":"2022031215402714500_B42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-2003-41810","article-title":"Secretory Zn2+-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated","volume":"35","author":"Gorska","year":"2003","journal-title":"Horm Metab Res"},{"key":"2022031215402714500_B43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0005-2760(97)00126-4","article-title":"Effects of sphingomyelin and phosphatidylcholine degradation on cyclodextrin-mediated cholesterol efflux in cultured fibroblasts","volume":"1349","author":"Ohvo","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"2022031215402714500_B44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI119171","article-title":"Diet-induced obese mice develop peripheral, but not central, resistance to leptin","volume":"99","author":"Van Heek","year":"1997","journal-title":"J Clin Invest"},{"key":"2022031215402714500_B45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1194\/jlr.M300310-JLR200","article-title":"Modification of LDL with human secretory phospholipase A(2) or sphingomyelinase promotes its arachidonic acid-releasing propensity","volume":"45","author":"Oestvang","year":"2004","journal-title":"J Lipid Res"},{"key":"2022031215402714500_B46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09687689709048166","article-title":"Mutual modulation of sphingomyelinase and phospholipase A2 activities against mixed lipid monolayers by their lipid intermediates and glycosphingolipids","volume":"14","author":"Fanani","year":"1997","journal-title":"Mol Membr Biol"},{"key":"2022031215402714500_B47","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/bi015757x","article-title":"Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin.","volume":"41","author":"Gesquiere","year":"2002","journal-title":"Biochemistry"},{"key":"2022031215402714500_B48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.ATV.0000257133.60884.44","article-title":"Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice","volume":"27","author":"Bostrom","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031215402714500_B49","doi-asserted-by":"crossref","first-page":"25913","DOI":"10.1074\/jbc.274.36.25913","article-title":"Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans","volume":"274","author":"Sartipy","year":"1999","journal-title":"J Biol Chem"},{"key":"2022031215402714500_B50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-9150(03)00007-8","article-title":"Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease","volume":"167","author":"Lee","year":"2003","journal-title":"Atherosclerosis"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/58\/9\/2018\/392522\/zdb00909002018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/58\/9\/2018\/392522\/zdb00909002018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:18:51Z","timestamp":1667405931000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/58\/9\/2018\/23892\/ApoCIII-Enriched-LDL-in-Type-2-Diabetes-Displays"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,5]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,6,5]]},"published-print":{"date-parts":[[2009,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db09-0206","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,5]]}}}